Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 3 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor TherapyNot yet recruitingNCT07596524
• Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%RecruitingNCT07596121Phase 2
• A Study of Ivonescimab in People With Non-Small Cell Lung CancerRecruitingNCT07594522Phase 1/2
• TCR1188-ABC Cells in KRAS-mutated CancersRecruitingNCT07594067Phase 1
• XR-Assisted PET/CT Navigation for Cervical Lymph Node Dissection in Lung CancerNot yet recruitingNCT07593872Not applicable
• Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid TumorsRecruitingNCT07589205Phase 1
• Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 2
• A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLCRecruitingNCT07586202Phase 2
• A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and LymphomaNot yet recruitingNCT07583771Phase 1
• Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung CancerRecruitingNCT07579221Phase 1/2
• A Phase 1 Study of IM-1617 in Participants With Advanced CancerRecruitingNCT07578571Phase 1
• Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingNCT07576725Phase 2
• Clinical Effects of Alpha-Lipoic Acid in Advanced NSCLCNot yet recruitingNCT07574684Phase 2
• Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and ChemotherapyNot yet recruitingNCT07573696Phase 2
• Adebrelimab or Retlirafusp Alfa Plus Recaticimab and Chemotherapy for Resectable NSCLCNot yet recruitingNCT07567326Phase 2
• A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationRecruitingNCT07566052Phase 3
• The APRIL Trial Evaluating Upfront Stereotactic Body Radiotherapy in Stage III Advanced Non-small Cell Lung CancerNot yet recruitingNCT07565987Not applicable
• Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)RecruitingNCT07564557Not applicable
• A 2-part Phase 1/2 Open-label Trial on ODM-212RecruitingNCT07563738Phase 1/2
• Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung CancerRecruitingNCT07563205
• IMP3-saRNA Vaccine in Advanced NSCLCRecruitingNCT07561723Phase 1
• Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation DeviceRecruitingNCT07561567
• Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung CancerNot yet recruitingNCT07560358Phase 3
• A Phase II Study of GC101 in NSCLCRecruitingNCT07560111Phase 2
• Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid TumorsNot yet recruitingNCT07558200Phase 1
• 18F-T2 PET/CT Imaging for CAIX Positive Solid TumorsRecruitingNCT07557225Not applicable
• Pilot Study of Bone Mineral Density Changes During Anti-PD-1 ImmunotherapyRecruitingNCT07555210Not applicable
• GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS G12D-Mutant Non-Small Cell Lung CancerNot yet recruitingNCT07554859Phase 2
• A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)RecruitingNCT07554339Phase 3
• Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid TumorsNot yet recruitingNCT07551778Phase 1/2
• Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKINot yet recruitingNCT07551414Phase 2
• A Lay Navigation Intervention for Patients With Lung CancerNot yet recruitingNCT07548788Not applicable
• A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based ChemotherapyRecruitingNCT07548060Phase 2
• Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver MetastasisNot yet recruitingNCT07545213Phase 2
• A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid MalignanciesNot yet recruitingNCT07542704Phase 1
• Barriers and Facilitators of Persistence With Adjuvant OsimertinibRecruitingNCT07542210
• A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT07541170Phase 3
• A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid TumorsRecruitingNCT07540572Phase 1
• Real-Time Imaging to Improve Lung Cancer Diagnosis : Comparing Confocal Laser Endomicroscopy (CLE) With Standard Biopsy for Quicker and Safer Detection of Non-Small Cell Lung CancerRecruitingNCT07538947
• A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung CancerRecruitingNCT07538804Phase 1/2
• Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung CancerNot yet recruitingNCT07538193Not applicable
• A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung CancerRecruitingNCT07535463Phase 1/2
• A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung CancerRecruitingNCT07535437Phase 1/2
• Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological TreatmentRecruitingNCT07529145
• Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy FailureRecruitingNCT07528274Phase 2
• JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II StudyRecruitingNCT07518160Phase 2
• Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II TrialNot yet recruitingNCT07517640Phase 2
• Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsRecruitingNCT07517198Phase 1
• A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)RecruitingNCT07513376Phase 3
• Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor TislelizumabRecruitingNCT07510724
• FL-261 Imaging for Cancer Diagnosis and StagingRecruitingNCT07510321
• MDT-Based Umbrella Decision Model for Geriatric Lung Cancer PatientsRecruitingNCT07509333Not applicable
• Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients With EGFR-mutant, Locally Advanced or Metastatic/Recurrent Non-Small Cell Lung Cancer (INSTAR Study)Not yet recruitingNCT07507188Phase 2
• Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung CancerRecruitingNCT07505173Phase 2
• A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors TypesRecruitingNCT07503808Phase 1
• Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon CancerNot yet recruitingNCT07502963Not applicable
• Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer SurgeryRecruitingNCT07500376
• Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)Not yet recruitingNCT07500285Phase 2
• FAP-targeted PET/NIR in Lung Malignant TumorsRecruitingNCT07498933
• TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLCNot yet recruitingNCT07498595Early Phase 1
• Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung CancerNot yet recruitingNCT07495098Phase 1
• Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer PatientsNot yet recruitingNCT07493980Phase 2
• A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung CancerRecruitingNCT07489716Phase 2
• SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLCNot yet recruitingNCT07489703Phase 2
• Concomitant Use of Radiotherapy and Integrated Exercise - Lung CancerRecruitingNCT07489391Not applicable
• Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCRecruitingNCT07489066Phase 2
• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsRecruitingNCT07488676Phase 1/2
• Cadherin 3(CDH3)-Targeted PET in Lung Malignant TumorsRecruitingNCT07487883
• Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L OsimertinibNot yet recruitingNCT07486648Phase 1/2
• Magnetic Resonance Imaging of the Lung: Oncological ApplicationsRecruitingNCT07486219
• Boosting Osimertinib Blood Brain Barrier PenetrationRecruitingNCT07485452Phase 2
• Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 InhibitorsRecruitingNCT07485114
• Fiber-Boost Randomized Controlled TrialRecruitingNCT07483112Not applicable
• Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural EffusionNot yet recruitingNCT07482605Phase 2
• Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled StudyNot yet recruitingNCT07479407Not applicable
• Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLCRecruitingNCT07479277Not applicable
• A Retrospective Real-World Study Based on RATIONALE-307RecruitingNCT07478809
• Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung CancerNot yet recruitingNCT07477808Phase 3
• Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung CancerRecruitingNCT07477158
• SYS6090 Combination Therapy in Advanced Lung CancerNot yet recruitingNCT07472647Phase 1/2
• Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)RecruitingNCT07472478Phase 2
• Pathophysiological Mechanisms Involved in the Pronostic and Evolution of Non-Small Cell Lung Cancer (NSCLC) at All Stages of the DiseaseNot yet recruitingNCT07470476
• A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer RisksRecruitingNCT07469709
• A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based RegimensNot yet recruitingNCT07469488Phase 4
• Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLCRecruitingNCT07467863Phase 1/2
• A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic AlterationsNot yet recruitingNCT07464327Phase 3
• Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT07463677Phase 2
• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCRecruitingNCT07462377Phase 1
• An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver MetastasesNot yet recruitingNCT07461727Phase 1
• Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)RecruitingNCT07460999Not applicable
• QLS5132 Combination Therapy in Advanced Solid TumorsNot yet recruitingNCT07453394Phase 1/2
• ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung CancerRecruitingNCT07452224Phase 2
• An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLCRecruitingNCT07452003Not applicable
• Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1Not yet recruitingNCT07450183Phase 2
• Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsRecruitingNCT07444814Phase 1
• A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung CancerRecruitingNCT07444437Phase 2
• SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase ⅢNot yet recruitingNCT07442565Phase 3
• PD-L1 Targeting Peptide Probe for PET Imaging of Solid TumorNot yet recruitingNCT07442292
• Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life WorkupRecruitingNCT07441941
• DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.RecruitingNCT07440290Phase 2/3

← Carcinoma, Non-Small-Cell Lung overview